Skip to main content
. 2013 Oct;23(5):493–500.

Table 3.

ICER of neonatal screening in Shiraz University of Medical Sciences, 2010

Type of disease Incremental cost (US$) Incremental QALYs ICER
Phenylketonuria - 33.714 0.001 Dominant
Congenital hypothyroidism - 755.43 0.0055 Dominant
Galactosemia - 42.174 0.002 Dominant
Favism -345.53 0.88540 Dominant

ICER: Incremental Cost Effectiveness Ratio; QALY: Quality-Adjusted Life Years